Henry Ford Enrolling Children for Moderna Vaccine Study
(May 27, 2021 4:19 PM) Henry Ford Health System announced today that it has opened enrollment for Moderna’s COVID-19 vaccine study for children ages 6 months to 11 years old. Henry Ford is the only enrollment site in Michigan for the vaccine study. The KidCOVE study will evaluate the safety and efficacy of Moderna’s mRNA-1273 vaccine for this group of young children. This is the same vaccine that was given Emergency Use Authorization by the FDA for adults 18 and older. Moderna said this week that it would apply for authorization in June to use the vaccine for 12- to 17-year-olds. To date, more than 122 million doses of the Moderna vaccine have been administered in the United States and more than 53 million people are fully vaccinated with it. KidCOVE is the fourth COVID-19 vaccine trial for which Henry Ford has been selected as a study site. The health system was a Phase 3 study site and the only Michigan site for Moderna’s two-dose adult vaccine and for Johnson & Johnson’s ENSEMBLE 1 one-dose and ENSEMBLE 2 two-dose adult vaccine. “The more vaccine candidates we have for our young people, the better,” said Adnan Munkarah, M.D., Executive Vice President…

